Suppr超能文献

男性近端尿道原发性鳞状细胞癌:单中心研究结果。

Primary Squamous Cell Carcinoma of the Male Proximal Urethra: Outcomes from a Single Centre.

机构信息

Department of Urology, University College London Hospital, London, UK; NIHR Biomedical Research Centre, University College London Hospital, London, UK; Division of Surgery and Interventional Science, University College London, London, UK.

Department of Urology, University College London Hospital, London, UK.

出版信息

Eur Urol Focus. 2021 Jan;7(1):163-169. doi: 10.1016/j.euf.2019.02.016. Epub 2019 Mar 7.

Abstract

BACKGROUND

Primary squamous cell carcinoma (SCC) of the male proximal urethra is an aggressive and rare urogenital malignancy.

OBJECTIVE

To review the surgical management and outcomes for male proximal urethral SCCs within a single centre and to suggest an algorithm for the surgical management of these rare tumours.

DESIGN, SETTING, AND PARTICIPANTS: This was a retrospective study of patients undergoing surgery for male proximal urethral SCC within a single tertiary academic centre managing rare genital tumours. Ten patients with a histological diagnosis of proximal urethral SCC were identified from an institutional database over a period of 10 yr with a median follow-up of 22.5 mo (standard deviation±25.77 mo).

OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS

Pathological staging, surgical treatment, and neoadjuvant and adjuvant treatment were recorded. Complications according to the Clavien-Dindo classification and overall survival rates were recorded. Kaplan-Meier curves were used for overall survival.

RESULTS AND LIMITATIONS

A total of 10 patients were identified of whom eight underwent panurethrectomy and radical prostatectomy. Radical inguinal lymphadenectomy was performed in five patients, which confirmed bilateral metastatic disease. Perioperative complications were reported in six patients (Clavien I and II). Within 6 mo of surgery, 90% of patients developed distant metastatic disease. Nine patients died of urethra cancer during the follow-up. One patient is still on follow-up. The median overall follow-up was 13.92 mo (range: 5-91 mo). At 5 yr, cancer-specific/overall survival was 10%. A limitation of this study is the retrospective design, which is unavoidable for such a rare disease.

CONCLUSIONS

Radical surgery allows local disease control, but despite neo/adjuvant treatment, proximal urethral SCC is associated with poor survival outcomes and progression to distant metastatic disease within 6 mo.

PATIENT SUMMARY

Proximal urethral squamous cell carcinoma is a rare cancer in men which is often detected late. Patients often present with problems such as voiding, urethral bleeding, or a palpable mass. Aggressive surgery allows local control, but despite this the overall survival is poor. Adjuvant and neoadjuvant radiochemotherapy can improve survival. Multicentric randomised trials are needed to identify the correct treatment modality.

摘要

背景

原发性男性近端尿道鳞癌(SCC)是一种侵袭性和罕见的泌尿生殖系统恶性肿瘤。

目的

回顾单一中心男性近端尿道 SCC 的手术治疗和结果,并提出这些罕见肿瘤的手术治疗方案。

设计、设置和参与者:这是一项对单一三级学术中心内接受手术治疗的男性近端尿道 SCC 患者的回顾性研究,该中心专门治疗罕见的生殖器肿瘤。在 10 年的时间里,从机构数据库中确定了 10 名患有近端尿道 SCC 组织学诊断的患者,中位随访时间为 22.5 个月(标准差±25.77 个月)。

结局测量和统计分析

记录了病理分期、手术治疗、新辅助和辅助治疗。记录了根据 Clavien-Dindo 分类的并发症和总生存率。使用 Kaplan-Meier 曲线进行总生存率分析。

结果和局限性

共确定了 10 名患者,其中 8 名患者接受了全尿道切除术和根治性前列腺切除术。5 名患者接受了根治性腹股沟淋巴结切除术,证实了双侧转移性疾病。6 名患者报告了围手术期并发症(Clavien I 和 II 级)。手术后 6 个月内,90%的患者发生远处转移。9 名患者在随访期间死于尿道癌。1 名患者仍在随访中。中位总随访时间为 13.92 个月(范围:5-91 个月)。5 年时,癌症特异性/总生存率为 10%。本研究的局限性在于这是一种罕见疾病,不可避免地采用了回顾性设计。

结论

根治性手术可以控制局部疾病,但尽管进行了新辅助/辅助治疗,近端尿道 SCC 仍与不良生存结局相关,并在 6 个月内发展为远处转移疾病。

患者总结

男性近端尿道鳞状细胞癌是一种罕见的癌症,通常发现较晚。患者常出现排尿困难、尿道出血或可触及肿块等问题。积极的手术可实现局部控制,但即便如此,整体生存率仍较差。辅助和新辅助放化疗可改善生存。需要进行多中心随机试验以确定正确的治疗方式。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验